Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Adenoid Cystic × cabozantinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 43 Carcinoma, Hepatocellular 12 Neoplasm Metastasis 7 Prostatic Neoplasms 6 Neoplasms 6 Kidney Neoplasms 6 Sarcoma 5 Osteosarcoma 5 Clear-cell metastatic renal cell carcinoma 5 Sarcoma, Ewing 4 Neuroendocrine Tumors 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma 4 Brain Neoplasms 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Thyroid Neoplasms 3 Ovarian Neoplasms 3 Melanoma 3 Endometrial Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Medullary 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Recurrence 2 Penile Neoplasms 2

Interventions

pembrolizumab 4 Magnetic Resonance Spectroscopy 3 lenvatinib 2 Specimen Handling 2 Nivolumab 2 Carboplatin 2 regorafenib 1 gallium 68 PSMA-11 1 enfortumab vedotin 1 amivantamab 1 Tablets 1 Surveys and Questionnaires 1 Standard of Care 1 Radiosurgery 1 Pemetrexed 1 Ipilimumab 1 Imatinib Mesylate 1 Glutamate Carboxypeptidase II 1 Etoposide 1 Epirubicin 1 Endoscopic Mucosal Resection 1 Cyclophosphamide 1 Combined Modality Therapy 1 Cisplatin 1 CTLA-4 Antigen 1 Blood Specimen Collection 1 BMS-906024 1 68Ga-DKFZ-PSMA-11 1 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡